{"DataElement":{"publicId":"11161038","version":"1","preferredName":"Criterion Intraocular Retinoblastoma Fulfill Type","preferredDefinition":"A description of the criterion that was met for intraocular retinoblastoma.","longName":"CRT_INTRAOC_RETBLAS_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"11161032","version":"1","preferredName":"Criterion Intraocular Retinoblastoma Fulfill","preferredDefinition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.:Retinoblastoma restricted to local involvement._Satisfy the requirements or expectations of.","longName":"8017360v1.00:11161031v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"8017360","version":"1","preferredName":"Criterion","preferredDefinition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","longName":"C25466","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D69E104F-C257-5DF7-E053-4EBD850A1AF6","latestVersionIndicator":"Yes","beginDate":"2022-01-28","endDate":null,"createdBy":"FEIBUSHL","dateCreated":"2022-01-28","modifiedBy":"ONEDATA","dateModified":"2022-01-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11161031","version":"1","preferredName":"Intraocular Retinoblastoma Fulfill","preferredDefinition":"Retinoblastoma restricted to local involvement._Satisfy the requirements or expectations of.","longName":"C7846:C87531","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraocular Retinoblastoma","conceptCode":"C7846","definition":"Retinoblastoma restricted to local involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fulfill","conceptCode":"C87531","definition":"Satisfy the requirements or expectations of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E77ADE27-D6ED-3E37-E053-731AD00A1276","latestVersionIndicator":"Yes","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E77ADE27-D6EE-3E37-E053-731AD00A1276","latestVersionIndicator":"Yes","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-09-28","changeDescription":null,"administrativeNotes":"2022.8.30 Created for ticket request CADSR0001468. ak 2022.9.28 Released per closed ticket. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"11161033","version":"1","preferredName":"Retinoblastoma Type","preferredDefinition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. Approximately 95% of cases are diagnosed before age 5. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma._Something distinguishable as an identifiable class based on common qualities.","longName":"RTNBLAS_TYP","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unilateral Group D retinoblastoma with vitreous seeding","valueDescription":null,"ValueMeaning":{"publicId":"11161034","version":"1","preferredName":"Unilateral Group D retinoblastoma with vitreous seeding","longName":"11161034v1.00","preferredDefinition":"Unilateral Group D retinoblastoma with vitreous seeding","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E77AFAC0-D92A-40FD-E053-731AD00AA246","latestVersionIndicator":"Yes","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E77AFAC0-D92E-40FD-E053-731AD00AA246","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","deletedIndicator":"No"},{"value":"Bilateral retinoblastoma with worst eye Group D, with vitreous seeding present and the contralateral eye is Group A-C","valueDescription":null,"ValueMeaning":{"publicId":"11161035","version":"1","preferredName":"Bilateral retinoblastoma with worst eye Group D, with vitreous seeding present and the contralateral eye is Group A-C","longName":"11161035v1.00","preferredDefinition":"Bilateral retinoblastoma with worst eye Group D, with vitreous seeding present and the contralateral eye is Group A-C","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E77AFAC0-D92B-40FD-E053-731AD00AA246","latestVersionIndicator":"Yes","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E77AFAC0-D92F-40FD-E053-731AD00AA246","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","deletedIndicator":"No"},{"value":"Bilateral retinoblastoma with one Group D eye with vitreous seeding and one Group E eye where the Group E eye has been enucleated prior to any therapy","valueDescription":null,"ValueMeaning":{"publicId":"11161036","version":"1","preferredName":"Bilateral retinoblastoma with one Group D eye with vitreous seeding and one Group E eye where the Group E eye has been enucleated prior to any therapy","longName":"11161036v1.00","preferredDefinition":"Bilateral retinoblastoma with one Group D eye with vitreous seeding and one Group E eye where the Group E eye has been enucleated prior to any therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E77AFAC0-D92C-40FD-E053-731AD00AA246","latestVersionIndicator":"Yes","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E77AFAC0-D930-40FD-E053-731AD00AA246","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","deletedIndicator":"No"},{"value":"Bilateral retinoblastoma with two Group D eyes with vitreous seeding","valueDescription":null,"ValueMeaning":{"publicId":"11161037","version":"1","preferredName":"Bilateral retinoblastoma with two Group D eyes with vitreous seeding","longName":"11161037v1.00","preferredDefinition":"Bilateral retinoblastoma with two Group D eyes with vitreous seeding","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E77AFAC0-D92D-40FD-E053-731AD00AA246","latestVersionIndicator":"Yes","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E77AFAC0-D931-40FD-E053-731AD00AA246","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-08-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4975682","version":"1","preferredName":"Retinoblastoma Type","preferredDefinition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.:Something distinguishable as an identifiable class based on common qualities.","longName":"C7541:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retinoblastoma","conceptCode":"C7541","definition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. Approximately 95% of cases are diagnosed before age 5. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DB30081-8EFF-9BBE-E050-BB89AD435B04","latestVersionIndicator":"Yes","beginDate":"2015-08-19","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-19","modifiedBy":"ONEDATA","dateModified":"2015-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E77AF25C-D974-4036-E053-731AD00A2172","latestVersionIndicator":"Yes","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-09-28","changeDescription":null,"administrativeNotes":"2022.8.30 Created for ticket request CADSR0001468. ak 2022.9.28 Released per review. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Which criterion was met for intraocular retinoblastoma?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Which criterion does the patient meet?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E77B0F98-F564-4388-E053-731AD00ADA93","latestVersionIndicator":"Yes","beginDate":"2022-08-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-30","modifiedBy":"KUMMEROA","dateModified":"2022-09-28","changeDescription":null,"administrativeNotes":"2022.8.30 Created for ticket request CADSR0001468. ak 2022.9.28 Released per closed ticket. ak","unresolvedIssues":null,"deletedIndicator":"No"}}